Systematic review synthesizes evidence on cognitive-behavioral therapy's efficacy in obsessive-compulsive disorder, highlighting treatment adherence and SSRIs.
Abstract Background: Obsessive-Compulsive Disorder (OCD) is a chronic and disabling psychiatric condition characterized by intrusive thoughts and repetitive behaviors. Cognitive-Behavioral Therapy (CBT), particularly Exposure and Response Prevention (ERP), is regarded as the gold-standard psychological treatment for OCD. However, variations in efficacy, treatment adherence, and methodological quality across studies warrant a comprehensive synthesis of the available evidence. Objective: To systematically review and synthesize current evidence on the efficacy, mechanisms, and clinical outcomes of Cognitive-Behavioral Therapy in the treatment of Obsessive-Compulsive Disorder. Methods: A systematic search was conducted in PubMed, Scopus, PsycINFO, and Web of Science databases from inception to March 2025. Eligible studies included randomized controlled trials, meta-analyses, and systematic reviews evaluating CBT interventions for adults with OCD. Data extraction and quality assessment were performed independently by two reviewers following PRISMA guidelines. Results: Thirty-eight studies met inclusion criteria. Across trials, CBT—particularly ERP-based protocols—consistently demonstrated significant symptom reduction compared with control and pharmacological-only conditions. Meta-analytic evidence indicates moderate-to-large effect sizes (Hedges’ g = 0.65–1.20). Combined treatment with selective serotonin reuptake inhibitors (SSRIs) showed enhanced efficacy in severe cases. Treatment adherence, therapist expertise, and comorbid depression were identified as key moderators of outcomes. Conclusion: CBT remains a highly effective and evidence-based intervention for OCD. Despite robust efficacy, heterogeneity in methodological design and patient characteristics underscores the need for standardized protocols and further exploration of individual predictors of treatment response.
No takes yet. Share an insight, caveat, or question.
Fernando Filipe Paulos Vieira (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: